Enzo Biochem Balance Sheet Health
Financial Health criteria checks 5/6
Enzo Biochem has a total shareholder equity of $69.0M and total debt of $3.9M, which brings its debt-to-equity ratio to 5.6%. Its total assets and total liabilities are $93.5M and $24.4M respectively.
Key information
5.6%
Debt to equity ratio
US$3.86m
Debt
Interest coverage ratio | n/a |
Cash | US$57.16m |
Equity | US$69.03m |
Total liabilities | US$24.44m |
Total assets | US$93.47m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0IHV's short term assets ($75.7M) exceed its short term liabilities ($21.7M).
Long Term Liabilities: 0IHV's short term assets ($75.7M) exceed its long term liabilities ($2.8M).
Debt to Equity History and Analysis
Debt Level: 0IHV has more cash than its total debt.
Reducing Debt: 0IHV's debt to equity ratio has increased from 5.2% to 5.6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0IHV has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 0IHV has sufficient cash runway for 1 years if free cash flow continues to reduce at historical rates of 34.5% each year.